Table 1: Case profiles *: disease (cases): prostate cancer(2), breast cancer(1), renal cancer(1), uterus cancer(1), bladder cancer(1), plastic surgery(1), dyalysis shunt(1), **: SU (mg per day) : glimepirid 1.3±1.1, glibencramid 5.6±3.1. ***: insulin dose (unit per day) 10.6±5.0.
Total
Number of cases(male/female) 73(40/33)
Number of procedures(male/female) 86(49/37)
Age(yrs) 69.5±11.0
NbA1c(%) 7.8±1.3
MBI 26.6±4.1
Disease durations(yrs) 11.7±10.7
Orthopedics operations Cardiac catheterization Ophthalmological operations Others
Number of cases(male/female) 40(17/23) 12(10/2) 13(9/4) 8(4/4)
Number of procedures(male/female) 43(18/25) 19(17/2) 18(12/6) 9(5/4)
Age 67.8±13.5 68.4±7.9 72.7±7.4 74.9±3.2
BMI 27.2±4.0 24.0±2.4 24.4±2.8 29.0±7.6
HbA1c(%) 7.4±1.1 8.6±1.8 8.6±1.1 7.6±0.5
Disease duration(yrs) 11.2±10.7 14.0±12.6 Unknown 9.5±7.8
Medications administered before Lira therapy
None 8 4 1 1 1
OAD Number of medications 1 5 0 1 1
2 15 2 5 3
3 3 2 0 0
4 5 1 0 0
With SU** 17 4 2 4
Insulin therapy*** 4 3 6 3
Fasting CPI 1.4±0.6 1.3±0.1 NM NM
uCPR(μ/day) 94.0±60.6 77.7 NM NM